Trial intelligence / Profile preview

SonoVue vs Sonazoid for CEUS-LIRADS in HCC

NCT04006275Phase 3Unknown

Sponsor
Second Affiliated Hospital of Zhejiang University School of Medicine
Start
Jun 2019
Primary completion
Dec 2019
Modality
Nanoparticles, Small Molecules
Countries
1
01

Overview

A Phase 3 trial of sulfur hexafluoride, sonazoid, sponsored by Second Affiliated Hospital of Zhejiang University School of Medicine. Status: unknown.

02

Drugs

sulfur hexafluoridesonazoid

Beyond the preview

Go deeper on NCT04006275.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04006275.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call